Asthma Self ManagementNCT06900361
Use of Mobile Phone Application for Asthma Sele Management
An observational study of Asthma Self Management, run by Kamuzu University of Health Sciences at 1 site in Malawi.
Trial summary
This study aimed to assess the feasibility and acceptability of self-management provided through a mobile application. Read more about this study
- Who is it for?
- Ages 10 to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Asthma Self Management
- How many people
- 17 participants
- Where
- 1 siteMalawi
- Study dates
- 11 Nov 2020to 30 Dec 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 10 to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: All asthma patients aged 10 years and over attending pediatric outpatient clinic.
Who may be able to join
- Be aged 10 years and over
- Have a Physician diagnosis of asthma and be prescribed a salbutamol inhaler
- Reside in Blantyre
- Participants should be able to read and write either English or Chichewa with Minimum standard 5 eductaion
Who cannot join
- Cognitively impaired
- Presence of coormobities
- Refues to consent
- Presence of active lung disease other than athsma
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Feasibility and Acceptability of Asthma Self-Management Delivered Through a Mobile Phone Application: A Pilot Study in Malawi
This study aimed to assess the feasibility and acceptability of self-management provided through a mobile application.
Read the detailed description
The chronic nature of asthma management requires a long-term approach taking into account the variability of disease symptoms, triggers and exacerbations. Several current guidelines advocate for self-management as part of standard care. Low-income countries (LMICs) such as Malawi are experiencing an increase in the burden of disease which hinders delivery of self-management services. Mobile phone health applications (mHealth) has been reported as an effective and cost-effective tool in the monitoring and management of asthma.
- Conditions
- Asthma Self Management
- Keywords
- Asthma Self Management
What is being measured
The primary outcome is the main question the study is designed to answer.
GINA Symptom Control Assessment
Asthma Control Test (ATC) Score
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Mar 2025
- Study start11 Nov 2020
- Primary completion30 Dec 2021
- Study completion30 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Asthma Self ManagementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 17 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kamuzu University of Health Sciences
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06900361
- Sponsor's protocol ID
- P.09/20/3132
- Other IDs
- 5U24HL136791
- Status last verified
- Mar 2025
- First submitted
- 26 Mar 2025
- Last updated
- 28 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The de-identified datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Publications
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention,2019. Available from www.ginasthma.org
Study at a glance
From the registry record, last updated by the sponsor on 28 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility and Acceptability of Asthma Self-Management Delivered Through a Mobile Phone Application: A Pilot Study in Malawi
- ClinicalTrials.gov ID
- NCT06900361
- Acronym / sponsor ID
- P.09/20/3132
- Conditions
- Asthma Self Management
- Keywords
- Asthma Self Management
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 17 participants (actual)
- Lead sponsor
- Kamuzu University of Health SciencesUniversity, hospital or other
- Study start
- 11 Nov 2020 (actual)
- Primary completion
- 30 Dec 2021 (actual)
- Study completion
- 30 Dec 2021 (actual)
- First posted
- 28 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to assess the feasibility and acceptability of self-management provided through a mobile application.
Detailed description
The chronic nature of asthma management requires a long-term approach taking into account the variability of disease symptoms, triggers and exacerbations. Several current guidelines advocate for self-management as part of standard care. Low-income countries (LMICs) such as Malawi are experiencing an increase in the burden of disease which hinders delivery of self-management services. Mobile phone health applications (mHealth) has been reported as an effective and cost-effective tool in the monitoring and management of asthma.
Study design
- Observational model
- Other
- Time perspective
- Other
Who may qualify
- Ages
- 10 to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- All asthma patients aged 10 years and over attending pediatric outpatient clinic.
Key inclusion criteria (4 listed)
- Be aged 10 years and over
- Have a Physician diagnosis of asthma and be prescribed a salbutamol inhaler
- Reside in Blantyre
- Participants should be able to read and write either English or Chichewa with Minimum standard 5 eductaion
Key exclusion criteria (4 listed)
- Cognitively impaired
- Presence of coormobities
- Refues to consent
- Presence of active lung disease other than athsma
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
GINA Symptom Control Assessment
Time frame: one year
Asthma Control Test (ATC) Score
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Mar 2025.
- Results publicationGlobal Initiative for Asthma. Global Strategy for Asthma Management and Prevention,2019. Available from www.ginasthma.org
- 8\. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention,2019Link provided by the sponsor.
- Individual participant dataSharing planned: Yes. The de-identified datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Related trials for Asthma Self Management
Not yet recruiting
R34 Asthma Depression
Asthma, Depression
Recruiting
SMART@Home Feasibility Trial
Asthma, Asthma in Children
Not yet recruiting
Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study
Asthma, Medication Adherence
Recruiting
Physical Activity Promotion and Clinical Remission in Severe Asthma
Severe Asthma
Recruiting
The Development of the Walsh Asthma Self-management Programme and Feasibility of Implementation in Adults With Asthma in Primary Care
Asthma, Self-management
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Asthma Self Management, run by Kamuzu University of Health Sciences at 1 site in Malawi.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Malawi. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
GINA Symptom Control Assessment (time frame: one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06900361, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2025.